Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

It is well known that students who prepare in advance perform better on exams. Now, it appears that the skin can do the same.Rather than scrambling to ...

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

Scientists at the Salk Institute for Biological Studies and Sanford Burnham Prebys explore genetic factors in separate papers ...

Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the close of a ...

此次启动的人体试验，针对的是两种导致失明的疾病。ER-100试验具体操作步骤是，采用腺相关病毒（AAV）作为载体，将三个基因Oct4、Sox2、Klf4（合称OSK），直接注射到患者眼球内部，使这些基因进入受损的视网膜神经节细胞。

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...